Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) DNA Repair Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global DNA Repair Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 PARP Inhibitors
      • 1.3.3 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global DNA Repair Drugs Market Share by Application (2019-2025)
      • 1.4.2 Oncological
      • 1.4.3 Stroke
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global DNA Repair Drugs Market Size
      • 2.1.1 Global DNA Repair Drugs Revenue 2014-2025
      • 2.1.2 Global DNA Repair Drugs Sales 2014-2025
    • 2.2 DNA Repair Drugs Growth Rate by Regions
      • 2.2.1 Global DNA Repair Drugs Sales by Regions 2014-2019
      • 2.2.2 Global DNA Repair Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 DNA Repair Drugs Sales by Manufacturers
      • 3.1.1 DNA Repair Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 DNA Repair Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 DNA Repair Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 DNA Repair Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global DNA Repair Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 DNA Repair Drugs Price by Manufacturers
    • 3.4 Key Manufacturers DNA Repair Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into DNA Repair Drugs Market
    • 3.6 Key Manufacturers DNA Repair Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 PARP Inhibitors Sales and Revenue (2014-2019)
      • 4.1.2 Other Sales and Revenue (2014-2019)
    • 4.2 Global DNA Repair Drugs Sales Market Share by Type
    • 4.3 Global DNA Repair Drugs Revenue Market Share by Type
    • 4.4 DNA Repair Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global DNA Repair Drugs Sales by Application

    6 United States

    • 6.1 United States DNA Repair Drugs Breakdown Data by Company
    • 6.2 United States DNA Repair Drugs Breakdown Data by Type
    • 6.3 United States DNA Repair Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union DNA Repair Drugs Breakdown Data by Company
    • 7.2 European Union DNA Repair Drugs Breakdown Data by Type
    • 7.3 European Union DNA Repair Drugs Breakdown Data by Application

    8 China

    • 8.1 China DNA Repair Drugs Breakdown Data by Company
    • 8.2 China DNA Repair Drugs Breakdown Data by Type
    • 8.3 China DNA Repair Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World DNA Repair Drugs Breakdown Data by Company
    • 9.2 Rest of World DNA Repair Drugs Breakdown Data by Type
    • 9.3 Rest of World DNA Repair Drugs Breakdown Data by Application
    • 9.4 Rest of World DNA Repair Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World DNA Repair Drugs Sales by Countries
      • 9.4.2 Rest of World DNA Repair Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 4SC AG
      • 10.1.1 4SC AG Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.1.4 DNA Repair Drugs Product Introduction
      • 10.1.5 4SC AG Recent Development
    • 10.2 ARCAGY/ GINECO GROUP
      • 10.2.1 ARCAGY/ GINECO GROUP Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.2.4 DNA Repair Drugs Product Introduction
      • 10.2.5 ARCAGY/ GINECO GROUP Recent Development
    • 10.3 Bristol Myers Squibb
      • 10.3.1 Bristol Myers Squibb Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.3.4 DNA Repair Drugs Product Introduction
      • 10.3.5 Bristol Myers Squibb Recent Development
    • 10.4 British Columbia Cancer Agency
      • 10.4.1 British Columbia Cancer Agency Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.4.4 DNA Repair Drugs Product Introduction
      • 10.4.5 British Columbia Cancer Agency Recent Development
    • 10.5 Cambridge University Hospitals NHS Foundation Trust
      • 10.5.1 Cambridge University Hospitals NHS Foundation Trust Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.5.4 DNA Repair Drugs Product Introduction
      • 10.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
    • 10.6 Genentech
      • 10.6.1 Genentech Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.6.4 DNA Repair Drugs Product Introduction
      • 10.6.5 Genentech Recent Development
    • 10.7 Georgetown University
      • 10.7.1 Georgetown University Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.7.4 DNA Repair Drugs Product Introduction
      • 10.7.5 Georgetown University Recent Development
    • 10.8 German Breast Group
      • 10.8.1 German Breast Group Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.8.4 DNA Repair Drugs Product Introduction
      • 10.8.5 German Breast Group Recent Development
    • 10.9 GlaxoSmithKline
      • 10.9.1 GlaxoSmithKline Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.9.4 DNA Repair Drugs Product Introduction
      • 10.9.5 GlaxoSmithKline Recent Development
    • 10.10 Jiangsu Hengrui Medicine
      • 10.10.1 Jiangsu Hengrui Medicine Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of DNA Repair Drugs
      • 10.10.4 DNA Repair Drugs Product Introduction
      • 10.10.5 Jiangsu Hengrui Medicine Recent Development
    • 10.11 Johnson & Johnson
    • 10.12 Jonsson Comprehensive Cancer Center
    • 10.13 Karyopharm Therapeutics
    • 10.14 KuDOS Pharmaceuticals
    • 10.15 National Health Service
    • 10.16 National Institutes of Health
    • 10.17 Tesaro

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 DNA Repair Drugs Sales Channels
      • 11.2.2 DNA Repair Drugs Distributors
    • 11.3 DNA Repair Drugs Customers

    12 Market Forecast

    • 12.1 Global DNA Repair Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global DNA Repair Drugs Sales Forecast by Type
    • 12.3 Global DNA Repair Drugs Sales Forecast by Application
    • 12.4 DNA Repair Drugs Forecast by Regions
      • 12.4.1 Global DNA Repair Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global DNA Repair Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
      In 2019, the market size of DNA Repair Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for DNA Repair Drugs.

      This report studies the global market size of DNA Repair Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the DNA Repair Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      4SC AG
      ARCAGY/ GINECO GROUP
      Bristol Myers Squibb
      British Columbia Cancer Agency
      Cambridge University Hospitals NHS Foundation Trust
      Genentech
      Georgetown University
      German Breast Group
      GlaxoSmithKline
      Jiangsu Hengrui Medicine
      Johnson & Johnson
      Jonsson Comprehensive Cancer Center
      Karyopharm Therapeutics
      KuDOS Pharmaceuticals
      National Health Service
      National Institutes of Health
      Tesaro

      Market Segment by Product Type
      PARP Inhibitors
      Other

      Market Segment by Application
      Oncological
      Stroke

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the DNA Repair Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key DNA Repair Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of DNA Repair Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now